nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—Gefitinib—lung cancer	0.22	0.339	CbGbCtD
Sulfisoxazole—CYP2C9—Teniposide—lung cancer	0.214	0.329	CbGbCtD
Sulfisoxazole—CYP2C9—Paclitaxel—lung cancer	0.119	0.184	CbGbCtD
Sulfisoxazole—CYP2C9—Cisplatin—lung cancer	0.096	0.148	CbGbCtD
Sulfisoxazole—EDNRA—mammary gland—lung cancer	0.0149	0.291	CbGeAlD
Sulfisoxazole—EDNRA—bronchus—lung cancer	0.00816	0.16	CbGeAlD
Sulfisoxazole—EDNRA—trachea—lung cancer	0.00733	0.144	CbGeAlD
Sulfisoxazole—EDNRA—cardiac atrium—lung cancer	0.00688	0.135	CbGeAlD
Sulfisoxazole—EDNRA—lung—lung cancer	0.00526	0.103	CbGeAlD
Sulfisoxazole—CYP2C9—mammary gland—lung cancer	0.00492	0.0964	CbGeAlD
Sulfisoxazole—EDNRA—lymph node—lung cancer	0.0036	0.0705	CbGeAlD
Sulfisoxazole—Sulfaphenazole—CYP2A6—lung cancer	0.00242	0.181	CrCbGaD
Sulfisoxazole—Sulfamethazine—ALB—lung cancer	0.00188	0.141	CrCbGaD
Sulfisoxazole—Sulfadiazine—CYP2E1—lung cancer	0.00188	0.141	CrCbGaD
Sulfisoxazole—Sulfamerazine—ALB—lung cancer	0.00183	0.138	CrCbGaD
Sulfisoxazole—Sulfamethizole—ALB—lung cancer	0.00142	0.107	CrCbGaD
Sulfisoxazole—Sulfanilamide—CYP2E1—lung cancer	0.00127	0.0955	CrCbGaD
Sulfisoxazole—Dapsone—CYP2E1—lung cancer	0.00114	0.0852	CrCbGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000918	0.00321	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—AVP—lung cancer	0.000917	0.00321	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—POMC—lung cancer	0.000909	0.00318	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000906	0.00317	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—APP—lung cancer	0.000898	0.00314	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM2—lung cancer	0.000885	0.00309	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CNDP2—lung cancer	0.000885	0.00309	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GRM8—lung cancer	0.000884	0.00309	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—AKT1—lung cancer	0.000881	0.00308	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000875	0.00306	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM2—lung cancer	0.000873	0.00305	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—lung cancer	0.000803	0.00281	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRM8—lung cancer	0.000802	0.00281	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2A7—lung cancer	0.0008	0.0028	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—ALB—lung cancer	0.000798	0.0599	CrCbGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2A7—lung cancer	0.000789	0.00276	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—lung cancer	0.000765	0.00268	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—lung cancer	0.000763	0.00267	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000744	0.0026	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AXL—lung cancer	0.000736	0.00257	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—OXTR—lung cancer	0.000728	0.00254	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GRP—lung cancer	0.000728	0.00254	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTA3—lung cancer	0.000713	0.00249	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTA3—lung cancer	0.000703	0.00246	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CXCL8—lung cancer	0.000703	0.00246	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS2—lung cancer	0.000701	0.0526	CrCbGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—AVP—lung cancer	0.000698	0.00244	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GNG11—lung cancer	0.000681	0.00238	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—lung cancer	0.000679	0.00237	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—OXTR—lung cancer	0.000661	0.00231	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRP—lung cancer	0.000661	0.00231	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000659	0.0023	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTA4—lung cancer	0.000652	0.00228	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000651	0.00227	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTA4—lung cancer	0.000643	0.00225	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTA2—lung cancer	0.000636	0.00222	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GNG11—lung cancer	0.000619	0.00216	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTA1—lung cancer	0.000613	0.00214	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADCY1—lung cancer	0.000612	0.00214	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	0.000609	0.00213	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—AKR1C1—lung cancer	0.000579	0.00202	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—COL4A2—lung cancer	0.000572	0.002	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—UGT1A1—lung cancer	0.00057	0.00199	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PTHLH—lung cancer	0.000569	0.00199	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—UGT1A1—lung cancer	0.000562	0.00197	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000561	0.00196	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GIPR—lung cancer	0.000557	0.00195	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADCY1—lung cancer	0.000556	0.00194	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PPP2R1B—lung cancer	0.000542	0.00189	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ANXA1—lung cancer	0.000535	0.00187	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000534	0.00187	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SDC4—lung cancer	0.00052	0.00182	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PTHLH—lung cancer	0.000517	0.00181	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—lung cancer	0.000511	0.00179	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DUSP3—lung cancer	0.00051	0.00178	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—APP—lung cancer	0.000507	0.00177	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RHEB—lung cancer	0.0005	0.00175	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000492	0.00172	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—lung cancer	0.000489	0.00171	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ANXA1—lung cancer	0.000486	0.0017	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—HPGDS—lung cancer	0.000485	0.00169	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM8—lung cancer	0.000474	0.00166	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	0.000471	0.00165	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTT1—lung cancer	0.00047	0.00164	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—lung cancer	0.000465	0.00163	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2A6—lung cancer	0.000465	0.00162	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GCLC—lung cancer	0.000465	0.00162	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—POMC—lung cancer	0.000464	0.00162	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—APP—lung cancer	0.000461	0.00161	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SKI—lung cancer	0.000459	0.0016	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—lung cancer	0.000454	0.00159	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—PIK3CA—lung cancer	0.000452	0.00158	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—lung cancer	0.00044	0.00154	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000425	0.00149	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—lung cancer	0.000404	0.00141	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PXN—lung cancer	0.000399	0.00139	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000398	0.00139	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2E1—lung cancer	0.000395	0.00138	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AVP—lung cancer	0.000395	0.00138	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRP—lung cancer	0.00039	0.00136	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKR1C1—lung cancer	0.00039	0.00136	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—OXTR—lung cancer	0.00039	0.00136	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2E1—lung cancer	0.00039	0.00136	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	0.000374	0.00131	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GNG11—lung cancer	0.000365	0.00128	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCL8—lung cancer	0.000359	0.00126	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AVP—lung cancer	0.000358	0.00125	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	0.000358	0.00125	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFC—lung cancer	0.000348	0.00122	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.00033	0.00116	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADCY1—lung cancer	0.000329	0.00115	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTP1—lung cancer	0.000326	0.00114	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTP1—lung cancer	0.000321	0.00112	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PPP2R1B—lung cancer	0.00032	0.00112	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SMARCA4—lung cancer	0.00032	0.00112	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HSPB1—lung cancer	0.000309	0.00108	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTHLH—lung cancer	0.000305	0.00107	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM1—lung cancer	0.000299	0.00105	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM1—lung cancer	0.000295	0.00103	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ANXA1—lung cancer	0.000287	0.001	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP1A1—lung cancer	0.000284	0.000993	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP1A1—lung cancer	0.00028	0.000979	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FLT1—lung cancer	0.000278	0.000972	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CG—lung cancer	0.000276	0.000963	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APP—lung cancer	0.000272	0.000952	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH3—lung cancer	0.000272	0.000952	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF9—lung cancer	0.00027	0.000944	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—POMC—lung cancer	0.000262	0.000917	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JUNB—lung cancer	0.000258	0.000901	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CG—lung cancer	0.00025	0.000875	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—COL4A3BP—lung cancer	0.00025	0.000873	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AZIN2—lung cancer	0.00025	0.000873	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CD—lung cancer	0.000242	0.000847	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—POMC—lung cancer	0.000238	0.000833	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STK11—lung cancer	0.000234	0.000818	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000233	0.000814	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6R—lung cancer	0.000232	0.000812	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FOXO3—lung cancer	0.000226	0.00079	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000226	0.000788	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAP2K1—lung cancer	0.000221	0.000774	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CD—lung cancer	0.00022	0.000769	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ATP5H—lung cancer	0.000212	0.000742	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AVP—lung cancer	0.000212	0.00074	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—POMC—lung cancer	0.000212	0.00074	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CB—lung cancer	0.000211	0.000738	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1R—lung cancer	0.000204	0.000712	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL8—lung cancer	0.000203	0.000709	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HES1—lung cancer	0.0002	0.0007	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RAF1—lung cancer	0.000196	0.000687	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000195	0.000682	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2—lung cancer	0.000194	0.000678	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CB—lung cancer	0.000192	0.00067	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLBD1—lung cancer	0.000189	0.000662	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000186	0.000651	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL8—lung cancer	0.000184	0.000644	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB3—lung cancer	0.000183	0.00064	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2—lung cancer	0.000176	0.000616	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TERT—lung cancer	0.000175	0.000613	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HSD17B10—lung cancer	0.000173	0.000605	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGFR1—lung cancer	0.00017	0.000596	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HIF1A—lung cancer	0.000168	0.000587	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APOA1—lung cancer	0.000162	0.000566	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CKB—lung cancer	0.000161	0.000563	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KDR—lung cancer	0.00016	0.000561	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CNDP2—lung cancer	0.000151	0.000529	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM2—lung cancer	0.000151	0.000529	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CG—lung cancer	0.000148	0.000517	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APC—lung cancer	0.000148	0.000517	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KIT—lung cancer	0.000148	0.000517	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NRAS—lung cancer	0.000148	0.000517	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTMR3—lung cancer	0.000147	0.000515	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGF—lung cancer	0.000146	0.000511	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PGAM1—lung cancer	0.000143	0.000501	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAPK3—lung cancer	0.000142	0.000495	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—POMC—lung cancer	0.000141	0.000492	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BRAF—lung cancer	0.000139	0.000486	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6R—lung cancer	0.000137	0.00048	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CREBBP—lung cancer	0.000137	0.000479	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2A7—lung cancer	0.000137	0.000478	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EGFR—lung cancer	0.000135	0.000471	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SDC4—lung cancer	0.000134	0.000468	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAP2K1—lung cancer	0.000131	0.000457	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CD—lung cancer	0.00013	0.000454	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CA—lung cancer	0.000129	0.00045	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KRAS—lung cancer	0.000127	0.000445	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA3—lung cancer	0.000122	0.000426	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—RRM1—lung cancer	0.000122	0.000426	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CA—lung cancer	0.000117	0.000409	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MDM2—lung cancer	0.000116	0.000407	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RAF1—lung cancer	0.000116	0.000406	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB2—lung cancer	0.000115	0.000401	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—B4GALT5—lung cancer	0.000115	0.000401	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MTOR—lung cancer	0.000113	0.000396	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CB—lung cancer	0.000113	0.000396	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA4—lung cancer	0.000112	0.00039	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000109	0.000381	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL8—lung cancer	0.000109	0.00038	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA2—lung cancer	0.000109	0.00038	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HRAS—lung cancer	0.000108	0.000378	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—lung cancer	0.000105	0.000368	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA1—lung cancer	0.000105	0.000367	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—lung cancer	0.000104	0.000364	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2—lung cancer	0.000104	0.000364	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCC3—lung cancer	0.000104	0.000363	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—lung cancer	0.000103	0.000362	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCND1—lung cancer	0.000101	0.000354	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JUN—lung cancer	0.000101	0.000354	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKR1C1—lung cancer	0.0001	0.000351	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP9—lung cancer	9.84e-05	0.000344	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1A—lung cancer	9.81e-05	0.000343	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTEN—lung cancer	9.79e-05	0.000342	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UGT1A1—lung cancer	9.75e-05	0.000341	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—lung cancer	9.55e-05	0.000334	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GNG11—lung cancer	9.4e-05	0.000329	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.35e-05	0.000327	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EP300—lung cancer	9.33e-05	0.000326	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SRC—lung cancer	9.08e-05	0.000317	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDOA—lung cancer	8.95e-05	0.000313	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—lung cancer	8.84e-05	0.000309	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT3—lung cancer	8.75e-05	0.000306	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NRAS—lung cancer	8.73e-05	0.000305	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOA3—lung cancer	8.69e-05	0.000304	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.54e-05	0.000299	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADCY1—lung cancer	8.45e-05	0.000296	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCG2—lung cancer	8.45e-05	0.000296	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK3—lung cancer	8.36e-05	0.000292	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HPGDS—lung cancer	8.29e-05	0.00029	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ENO2—lung cancer	8.29e-05	0.00029	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPP2R1B—lung cancer	8.24e-05	0.000288	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MYC—lung cancer	8.13e-05	0.000284	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.13e-05	0.000284	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTT1—lung cancer	8.04e-05	0.000281	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGFR—lung cancer	7.95e-05	0.000278	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GCLC—lung cancer	7.95e-05	0.000278	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2A6—lung cancer	7.95e-05	0.000278	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.92e-05	0.000277	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ENO1—lung cancer	7.53e-05	0.000263	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KRAS—lung cancer	7.51e-05	0.000263	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.51e-05	0.000262	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.41e-05	0.000259	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CA—lung cancer	6.9e-05	0.000241	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2E1—lung cancer	6.76e-05	0.000236	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NQO1—lung cancer	6.68e-05	0.000234	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TP53—lung cancer	6.68e-05	0.000234	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.54e-05	0.000229	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.48e-05	0.000227	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HRAS—lung cancer	6.39e-05	0.000223	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—lung cancer	6.11e-05	0.000214	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—STK11—lung cancer	6.02e-05	0.000211	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.65e-05	0.000198	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—lung cancer	5.64e-05	0.000197	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTP1—lung cancer	5.57e-05	0.000195	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAT—lung cancer	5.42e-05	0.00019	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.39e-05	0.000189	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCB1—lung cancer	5.28e-05	0.000184	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TYMS—lung cancer	5.18e-05	0.000181	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM1—lung cancer	5.12e-05	0.000179	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP1A1—lung cancer	4.86e-05	0.00017	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ERCC2—lung cancer	4.82e-05	0.000168	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOA1—lung cancer	4.17e-05	0.000146	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.99e-05	0.000139	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CG—lung cancer	3.8e-05	0.000133	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—POMC—lung cancer	3.62e-05	0.000127	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CREBBP—lung cancer	3.53e-05	0.000123	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CD—lung cancer	3.34e-05	0.000117	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALB—lung cancer	3.3e-05	0.000115	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CB—lung cancer	2.91e-05	0.000102	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—lung cancer	2.89e-05	0.000101	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTEN—lung cancer	2.52e-05	8.8e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—EP300—lung cancer	2.4e-05	8.4e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CA—lung cancer	1.78e-05	6.21e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—lung cancer	1.45e-05	5.07e-05	CbGpPWpGaD
